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Abstract
·AIM: To assess choroidal thickness in patients with
severe obstructive sleep apnea syndrome (OSAS) and
compare them with healthy controls, using spectral
domain optical coherence tomography (OCT).
·METHODS: In this observational, cross-sectional study,
choroidal thicknesses of 23 newly severe OSAS patients
and 23 body mass index- age- and sex-matched healthy
subjects were measured using a high -speed, high -
resolution frequency domain -OCT device (姿=840 nm,
26 000 A -scans/s, 5 滋m axial resolution). All patients
underwent a complete ophthalmic examination before the
measurements. OCT measurements were taken at the
same time of day (9:00 a.m.), in order to minimize the
effects of diurnal variation.
·RESULTS: There was a statistically significant
difference in median choroidal thickness between the
OSAS patients (201 滋m; range 145 -237 滋m) and the
controls (324 滋m; range 296 -383 滋m; <0.001). There
were significant differences at all measurement points
( <0.001 for all). The apnea -hypopnea index (AHI)
values were more than 30 in all OSAS patients and the
mean AHI was 48.57 依6.54. The interexaminer intraclass
correlation coefficient (ICC) for the mean choroidal
thickness was 0.938 (95%CI, 0.908-0.985) and ICC was
greater than 0.90 for all measurement points.
·CONCLUSION: The decreased choroidal thickness of
patients with severe OSAS might be related to the the
autonomic disregulation associated with this disease.
Further studies are needed to evaluate the etiopathologic
relationship between choroidal thickness and OSAS.
·KEYWORDS: choroidal thickness; optical coherence
tomography; obstructive sleep apnea syndrome
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INTRODUCTION
O bstructive sleep apnea syndrome (OSAS) is defined asrepeated episodes of upper airway obstruction during
sleep, leading to periods of hypoxemia and hypercapnia [1]. It
is characterized by snoring, excessive daytime sleepness,
chronic fatigue, and decreased cognitive abilities. The
prevelance of OSAS is 2%-4% in the middle age population.
Risk factors include obesity, male gender, thick neck,
consumption of alcohol, and abnormal upper respiratory
tract. Diagnosis of OSAS is made by overnight
polisomnography (PSG)[2,3].
OSAS-related hypoxia, hypercapnia, and decreased oxygen
saturation have been shown to generate systemic and
pulmonary hypertension, atherosclerosis, coronary artery
disease, and increased intracranial pressure [4,5]. Recent
evidence suggests that inflammatory processes, oxidative
stress, endothelial dysfunction and vascular remodelling may
play roles in the pathogenesis of vascular complications in
OSAS [6,7]. OSAS can also be responsible for autonomic
dysfunction with high sympathetic tone and elevated muscle
sympathetic nerve activity[7].
There have been several reports that OSAS is also associated
with ophthalmic disordes, including glaucoma, floppy eyelid
syndrome, nonarteritic anterior ischemic optic neuropathy
(NAION), optic disc edema, retinal vein occlusions, and
central serous chorioretinopathy (CSCR) [8-14].
In several recent studies, optical coherence tomography
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(OCT) was introduced as an effective tool for evaluating
choroidal thickness [15]. New-generation spectral domain OCT
devices with enhanced scanning speed provide the
opportunity to achieve high-resolution images and more
accurate measurements. Thus, it has become possible to
evaluate ocular tissues located at deeper levels than that of
the retina, which was not possible with time domain OCT[16-18].
In recent studies, a decreased retinal nerve fiber layer
thickness and increased optic nerve head area-volume
parameters measured with OCT have been reported in
patients with OSAS [19,20]. But, there have not been any reports
to investigate choroidal thickness in patients with OSAS.
Therefore, we intended to evaluate the choroidal thickness of
patients with severe OSAS and to compare them with that of
healthy controls.
SUBJECTS AND METHODS
Twenty-three newly diagnosed OSAS patients who have
apnea-hypopnea index (AHI) >30 (regarded as severe OSAS)
(20 males and 3 females) and 23 control subjects (20 males
and 3 females) were consecutively enrolled in this
case-control prospective study. Patients suspected of
clinically of having OSAS examinated and underwent
standart overnight PSG in the "Sleep Unit" of the Pulmonary
Medicine department of our university. OSAS was diagnosed
and graded according to the AHI values. Diagnosis of OSAS
was made when the AHI was over 5. When the AHI was
between 5/h and 15/h, OSAS was regarded as "mild",
between 16/h and 30/h as "moderate", and when it was over
than 30/h, it was regarded as "severe". After
polysomnographic study, patients with an AHI 逸30 were
considered as severe OSAS and AHI <5 were included as
control subjects that were matched 1:1 with OSAS patients
for body mass index (BMI), sex, and age.
The study protocol was approved by the local ethics
committee of Baskent University School of Medicine. The
research adhered to the tenets of the Declaration of Helsinki,
and a detailed written informed consent form was obtained
prior to each individual's participation in the study. Patients
with a history of ocular surgery, ocular trauma, anterior or
posterior segment disease, glaucoma, heavy smoking, alcohol
abuse, bronchial asthma, interstitial lung diseases,
cerebrovascular disease, systemic hypertension, diabetes
mellitus were excluded from the study. Patients who were
using any systemic or ocular drug were also excluded. Blood
pressure values were between 110/80 mm Hg and
130/90 mm Hg in all patients. Moreover, in order to obtain
clear images and to minimize the effect of axial length on
choroidal thickness, patients with best corrected visual acuity
worse than 20/20 and a refractive error higher than 1 D were
excluded from the study[21].
All patients underwent a detailed ophthalmic examination,
including visual acuity testing, refraction assessment,
biomicroscopy, intraocular pressure measurement with
non-contact tonometry, fundus examination, and choroidal
thickness measurements by OCT. One eye per patient was
randomly selected for OCT measurement. Randomization
was done using a random number generator.
Choroidal thickness measurements were performed by the
same experienced technician using a high-speed and
high-resolution spectral-domain OCT device (姿=840 nm,
26000 A-scans/s, and 5 滋m axial resolution), and results
were analyzed using Optovue RTVue software version 3.5
(Optovue Inc., Fremont, CA, USA). The scan pattern was the
retina cross line, consisting of 2 orthogonally oriented 6-mm
lines that contained 1024 A-scans. By automatically inverting
the image, the chorioretinal interface became adjacent to the
zero delay. The retina cross-line scan had 32 frames in
average, 16 per direction, without tracking[22].
Choroidal thickness was measured perpendicularly from the
outer edge of the retinal pigment epithelium to the
choroid-sclera boundary at the fovea and at 7 more points
located at fovea, at 500 滋m nasal to the fovea, 1000 滋m
nasal to the fovea, 1500 滋m nasal to the fovea; 500 滋m
temporal to the fovea, 1000 滋m temporal to the fovea, and
1500 滋m temporal to the fovea (Figure 1). Choroidal
thickness measurements were performed by two masked
physicians (Karalezli A and Eroglu FC). All basal OCT scans
were performed at the same time of the day (in the morning)
to avoid diurnal fluctuations [23]. The average of the two
measurements was taken; the differences between readings of
the masked physicians were found to be within 10 滋m of the
Figure 1 Choroidal thickness measurements of a patient
T-1500: Choroidal thickness at 1500 滋m temporal to the fovea;
T-1000: Choroidal thickness at 1000 滋m temporal to the fovea;
T-500: Choroidal thickness at 500 滋m temporal to the fovea; F:
Choroidal thickness at fovea; N-500: Choroidal thickness at 500 滋m
nasal to the fovea; N-1000: Choroidal thickness at 1000 滋m nasal to
the fovea, N-1500: Choroidal thickness at 1500 滋m nasal to the
fovea.
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mean. The inter examiner reproducibility of the choroidal
thickness measurements was assessed by measuring the
intraclass correlation coefficient (ICC).
Statistical Analysis Statistical analysis was performed using
the statistical package SPSS v15.0 (SPSS Inc., Chicago,
USA, 2006). Data were analyzed by Mann-Whitney test.
The categorical variables between the groups were analyzed
using the 2 test and to quantify the reproducibility of manual
re-measurements of the choroidal thickness in cases of
alignment errors, the ICC was calculated. The value <0.05
was considered statistically significant
RESULTS
The mean age of the OSAS patients was 58.6依9.7y (range
42-84y) and that of the controls was 58.2 依7.1y (range
43-82y). There was no statistically significant difference in
age between the groups ( =0.765). The AHI values were
more than 30 in all OSAS patients and the mean AHI was
48.57依6.54 (regarding as several OSAS).
The median choroidal thickness was measured as 201 滋m
(range 145-237 滋m) in OSAS patients and 324 滋m (range
296-383 滋m) in the control subjects. The median choroidal
thickness was statistically significant between groups
( <0 . 001 ) . Moreover, as shown in Figure 2, the choroidal
thicknesses of the patients with OSAS were all thinner than
those of the controls in all eyes and at all seven measurement
points.
The interexaminer ICC for the choroidal thickness was 0.938
(95%CI, 0.908-0.985) and ICC was greater than 0.90 for all
measurement points. Figure 3 shows the comparison of the
median chroidal thichness measurements by two different
observers in OSAS and control groups.
DISCUSSION
There are many reports in the literature that show the
association between OSAS and many ocular disorders [8-14].
Intermittent airway obstruction in OSAS causes hypoxia and
decrease main saturation of oxygen. Recurrent hypoxia and
reperfusion episodes can lead to oxidative stress and
inflammation, and also damage vascular endothelium and
decreased responsiveness to vasodilatator agents, such as
nitric oxide (NO). Moreover, drop in oxygen saturation leads
to activation of the adrenergic system, high sympathetic tone
and elevated muscle sympathetic nerve activity[7]. All of these
conditions lead to vascular dysregulation, autonomic
dysfunction and altered blood flow, because of imbalanced of
vasodilatation and vasoconstriction [7,24]. This vascular
phenomenon might compromise optic nerve perfusion and
oxygenation, and several authors have mentioned a high
prevalence of NAION and glaucoma in OSAS patients [11,12].
Retinal vein occlusions have been associated with OSAS as
they may be result of a slowdown of blood circulation
secondary to hypoxemia [13]. OSAS also has been recognized
to be a risk factor for CSCR, because of elevated levels of
circulating catecholamines in patients with OSAS[5].
The ocular blood flow can be assessed using color duplex
imaging, laser speckle method, or Doppler flowmetry [25-27].
However, because the choroid receives aproximately 95% of
all ocular blood flow, changes in its structure would help to
evaluate choroidal, thus ocular blood flow[25-27].
Therefore, a precise clinical understanding of choroidal
morphology should be important for understanding of the
pathogenesis of many retinal and choroidal disease[28]. Certain
Figure 2 Choroidal thickness measurements in OSAS patients
and control subjects N-1500: Choroidal thickness at 1500 滋m
nasal to the fovea; N-1000: Choroidal thickness at 1000 滋m nasal to
the fovea; N-500: Choroidal thickness at 500 滋m nasal to the fovea;
F: Choroidal thickness at fovea; T-500: Choroidal thickness at 500
滋m temporal to the fovea; T-1000: Choroidal thickness at 1000 滋m
temporal to the fovea; T-1500: Choroidal thickness at 1500 滋m
temporal to the fovea.
Figure 3 Comparison of the choroidal thickness measurements
of the OSAS patients and control subjects between two
different observers N-1500: Choroidal thickness at 1500 滋m nasal
to the fovea; N-1000: Choroidal thickness at 1000 滋m nasal to the
fovea; N-500: Choroidal thickness at 500 滋m nasal to the fovea; F:
Choroidal thickness at fovea; T-500: Choroidal thickness at 500 滋m
temporal to the fovea; T-1000: Choroidal thickness at 1000 滋m
temporal to the fovea; T-1500: Choroidal thickness at 1500 滋m
temporal to the fovea.
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characteristics of the choroid have been challenging to study
histologically. To date, spectral domain OCT featuring high
resolution and scanning speeds has allowed the choriod to be
accesed [22]. Spaide [29] described a "enhanced
deep imaging" (EDI) technique to optimize the parameters of
OCT and this tecnique allows to visualise the full thickness
of the choroid.
In the recent clinical studies, choroidal thickness was
reported significantly decreased in patients with pathologic
myopia, age-related macular degeneration, glaucoma and
diabetic retinopathy or increased in patients with
Voght-Koyanagi-Harada disease and CSCR [30-34]. In these
studies, the authors speculated that abnormal choroidal
thickness may be associated with choroidal circulation.
Sogawa [35] reported that there were no correlation
between the choroidal thickness and choroidal blood flow in
the healthy young subjects. But, in two different studies, the
authors mentioned that sildenafil citrate increases choroidal
thickness because of a vasodilatory effect of sildenafil citrate
on the choroidal circulation[36,37].
There are several studies related to choroidal blood flow in
the patients with OSAS [38,39]. Tonini [38] reported that
choroidal vascular response to hypoxia or hyperoxia does not
alter in the patients with OSAS. Khayi [39] also reported
that choroidal vascular changes in blood pressure were
similar to healthy subjects. This result was explained with an
autoregulation mechanism of the choroid. Contrary to retinal
and optic nerve head vasculature, choroid vessels are
subjected to autonomic regulation. But, ability to
authoregulate of the choroid may be altered in smokers,
age-related maculopathy, CSCR and glaucoma[40-43].
In our study, we showed that the median choroidal thickness
was statistically thinner in the eye of patients with severe
OSAS than that of the controls. We think that hypoxia and
reperfusion episodes are responsible for pathophysiology of
the OSAS, and these episodes cause oxidative stress,
inflammation, damage to vascular endothelium and decreased
responsiveness of the vessels to nitric oxide. Insufficient
vasodilatation of vessels may lead to decrease in choroidal
blood flow. We speculated that impaired autoregulation of
the choroid in severe OSAS may be responsible for thinner
choroidal thickness than that of controls.
There is a shortcoming regarding our study. A larger cohort
would have allowed more meaningful analysis on the relation
between the severity of OSAS and choroidal thickness;
however, this can be achieved in a further study based on the
preliminary findings of this study. Moreover, the design of
the study with age, BMI and sex-matched control group and
high ICCs between the two operators (ICC>0.90, for all
measurement points) make the results more valuable.
In conclusion, patients with severe OSAS tend to have
thinner choroids than healthy individuals, which in turn,
might be a result of the autonomic disregulation associated
with this disease. Further studies with larger subgroups of this
disease, including mild-modarete OSAS, are necessary to
come to a more definite conclusion.
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